Evidence map›Paper›PMID 38595871›Full record

ArticleCureus2024

Fibrolamellar Hepatocellular Carcinoma (FLHCC) in a Young Patient Presenting With Nausea and Vomiting After a Greasy Meal.

Mohamed Ismail, Sahiba Singh, Menna-Allah Elaskandrany, David S Kim, Yazan Abboud, Michael Bebawy, Abena Oduro, Ritik Mahaveer Goyal, Omar Mohamed, Weizheng Wang

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Mohamed IsmailDepartment of Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Sahiba SinghCollege of Osteopathic Medicine, Michigan State University, East Lansing, USA.
Menna-Allah ElaskandranyDepartment of Internal Medicine, Lenox Hill Hospital, New York, USA.
David S KimDepartment of Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Yazan AbboudDepartment of Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Michael BebawyDepartment of Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Abena OduroDepartment of Internal Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Ritik Mahaveer GoyalDepartment of Internal Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Omar MohamedDepartment of Medicine, Saint Barnabas Medical Center, Livingston, USA.
Weizheng WangGastroenterology and Hepatology, Rutgers University New Jersey Medical School, Newark, USA.
Saint Barnabas Medical Center · USMichigan State University · USLenox Hill Hospital · USRutgers New Jersey Medical SchoolRutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare and distinct subtype of liver cancer, predominantly affecting younger patients without underlying liver diseases. This case report discusses a unique presentation of FLHCC in a 38-year-old male with a past medical history of a well-controlled seizure disorder. The patient presented with nausea, vomiting, and abdominal pain following a fatty meal. Laboratory tests revealed elevated liver enzymes and anemia, and imaging showed a large hepatic lesion. Initial management included a septic workup and broad-spectrum antibiotics. However, a liver biopsy performed subsequently revealed the presence of FLHCC. The patient underwent a successful open right hepatectomy and was managed postoperatively with consideration of his seizure disorder. Follow-up at six months showed a stable postoperative condition without any evidence of recurrence. The diagnosis of FLHCC is challenging due to its rarity and nonspecific presentation. The case emphasizes the importance of considering FLHCC in the differential diagnosis of hepatic lesions, particularly in young patients. Surgical resection remains the primary treatment modality. This case underscores the importance of a thorough evaluation of hepatic lesions, especially in younger patients. It also illustrates the complexities in managing patients with FLHCC, requiring a multidisciplinary approach for optimal outcomes. Further research is necessary to better understand the pathogenesis of FLHCC and to develop more effective treatment strategies.

Indexed as

elevated liver enzymefibrolamellar hepatocellular carcinomahepatic lesionnausea and vomitingnon specific abdominal pain

Identifiers

PMID38595871
PMCPMC11002470
OpenAlexW4392756179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.